Xylem Inc. (XYL) stock analysis
Close on Nov 12, 2026Market cap $21.56BP/E 20.8Yield 1.70%
StockData Score
Prices as of Nov 11, 2026How the score works
Strong24 of 30 checks passed
Xylem passes 24 of the 30 checks behind our score. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 6/6
- Growth
- 4/6
- Past performance
- 4/6
- Financial health
- 6/6
- Dividend
- 4/6
What stands out
Margin of safety over 20%
The price is 28.5% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $95.11 is below our fair value estimate of $133.09.
Low debt
Debt is 28.2% of shareholders' equity, under the 40% we consider low.
Earnings grew over 5 years
Net income grew 30.4% a year on average over the last five fiscal years.
What to watch
Return on equity under 15%
Return on equity was 10.1% over the last twelve months and averaged 10.1% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 9.0%, below the 10% that usually covers the cost of capital.
Earnings growth not accelerating
Net income grew 14.1% over the last twelve months, against a 5-year average of 30.4% a year.
Growing slower than the industry
Revenue grew 1.9% over the last twelve months; the General Industrial Machinery and Equipment median is 12.4%.
Valuation6/6
P/E below its 5-year median
Xylem's P/E of 21.0 is below its own 5-year median of 38.7.
P/E below the industry
Xylem's P/E of 21.0 is below the General Industrial Machinery and Equipment median of 26.9.
EV/EBITDA below its 5-year median
Xylem's EV/EBITDA of 17.5 is below its 5-year median of 23.5.
P/B below the industry
Xylem's price-to-book of 2.12 is below the General Industrial Machinery and Equipment median of 2.84.
Trading below fair value
The share price of $95.11 is below our fair value estimate of $133.09.
Margin of safety over 20%
The price is 28.5% below fair value, more than the 20% cushion we look for.
Growth4/6
Revenue growing 10%+ a year
Revenue grew 17.8% a year over the last three fiscal years.
EPS growing 10%+ a year
Diluted EPS grew 26.0% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew 14.1% over the last twelve months, against a 5-year average of 30.4% a year.
Growing slower than the industry
Revenue grew 1.9% over the last twelve months; the General Industrial Machinery and Equipment median is 12.4%.
Guidance raised
Xylem raised its full-year 2026 revenue outlook on Jul 28, 2026.
Gross margin improving
Gross margin was 39.8% over the last twelve months, against 38.2% a year earlier.
Past performance4/6
Return on equity under 15%
Return on equity was 10.1% over the last twelve months and averaged 10.1% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 9.0%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Xylem's return on equity of 10.1% is above the General Industrial Machinery and Equipment median of 9.9%.
Earnings grew over 5 years
Net income grew 30.4% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 11.9% over the last twelve months, against a 5-year average of 8.8%.
Net margin above the industry
Xylem's net margin of 11.9% is above the General Industrial Machinery and Equipment median of 8.0%.
Financial health6/6
Low debt
Debt is 28.2% of shareholders' equity, under the 40% we consider low.
Debt falling against equity
Debt to equity fell from 104% five years ago to 28.2%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 43.9% of total debt.
Interest well covered
Operating income covers interest expense 36.1 times.
Short-term assets cover short-term debts
Current assets are 1.39 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 3.12; above 3 is the safe zone and below 1.8 the distress zone.
Dividend4/6
Pays a dividend
Xylem paid dividends worth 1.8% of the share price over the last twelve months.
Yield below Treasuries
The 1.8% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Xylem yields 1.8%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 37.4% of net income.
Covered by free cash flow
Dividends take 44.0% of free cash flow.
Fair value
How we estimate itOur estimate per share
$133.09
The share price is 29% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 32.8× | 38.7× | 26.9× | $148.47 | 47% |
| EV/EBITDA | 20.9× | 23.5× | 18.3× | $115.65 | 41% |
| P/B | 3.0× | 3.1× | 2.8× | $132.63 | 12% |
| Earnings powerleft out, too far from the others | 9.8% cost of equity | – | – | $35.76 | – |
| Fair value | $133.09 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 38.7
- General Industrial Machinery and Equipment median 26.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $312.00M
- Value traded per 1% price move
- $206.84M
Downside
Low risk
- Typical loss in a bad month
- 12.9%
- Volatility (annualized)
- 31%
- Sharpe ratio, 1 year
- -1.35
- Beta to the S&P 500 (5Y)
- 0.99
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +5.5% | +17.8% | +13.1% | +9.5% | |
| Gross profit | +8.2% | +18.6% | +13.7% | +9.5% | |
| Operating income | +21.2% | +25.3% | +27.2% | +10.5% | |
| Net income | +7.5% | +39.2% | +30.4% | +10.9% | |
| EPS, diluted | +7.4% | +26.0% | +22.9% | +7.7% | |
| Free cash flow | -3.4% | +32.9% | +7.3% | +10.1% | |
| Dividend per share | +11.1% | +10.1% | +9.0% | +11.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 12.2% | 8.6% | 8.7% | |
| Return on assets | 4.7% | 3.1% | 5.6% | |
| Current ratio | 1.49 | 1.80 | 1.63 | |
| Debt to equity | 1.08 | 1.04 | 0.17 | |
| Net debt to EBITDA | 3.69× | 1.96× | 0.26× | |
| Interest coverage | 5.8× | 4.8× | 42.2× | |
| Inventory turnover | 4.8× | 5.6× | 5.6× | |
| Capex to revenue | 3.3% | 3.8% | 3.7% | |
| Diluted shares | 180M | 181M | 244M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Xylem generated $4.48B from operations and spent $2.98B on capital expenditure, dividends and share buybacks. 45% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 10.6% | 0.53× | 1.54× | 8.7% |
| FY2024 | 10.4% | 0.53× | 1.57× | 8.6% |
| FY2023 | 8.3% | 0.61× | 1.76× | 8.9% |
| FY2022 | 6.4% | 0.68× | 2.42× | 10.6% |
| FY2021 | 8.2% | 0.61× | 2.75× | 13.8% |
| FY2020 | 5.2% | 0.59× | 2.78× | 8.6% |
| FY2019 | 7.6% | 0.70× | 2.61× | 14.0% |
| FY2018 | 10.5% | 0.74× | 2.67× | 20.8% |
| FY2017 | 7.0% | 0.71× | 2.84× | 14.1% |
| FY2016 | 6.9% | 0.68× | 2.60× | 12.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$957.00M
- Cash generatingOperating cash flow above zero$1.24B
- Return on assets improvedROA up on the prior year5.5% → 5.8%
- Earnings backed by cashOperating cash flow above net income$1.24B vs $957.00M
- Less leverageLong-term debt to assets fell12.0% → 8.0%
- Better liquidityCurrent ratio rose1.75 → 1.63
- No dilutionShare count did not rise244M → 244M
- Gross margin improvedGross margin up on the prior year37.51% → 38.46%
- More efficientAsset turnover rose0.53 → 0.55
See a number that looks wrong?